HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparative study of the effectiveness of 9,33"-diacetylmidecamycin (MOM) and midecamycin on respiratory tract infection].

AuthorsK Hara, K Izumikawa, M Komori, M Fukui, H Iwasaki, H Tomita, N Suyama, M Sai, A Saito, M Nakatomi, A Saito, M Tomizawa, I Nakayama, Y Kinoshita, S Kosaka, M Nakamura, S Arai, I Honda, I Hayashi, T Aoyagi, M Katsu, S Okui, M Adachi, K Nakagawa, M Koyama, H Tanimoto, K Nakada, A Tachibana, K Suzuki, H Kobayashi, M Takamura, I Fujimori, T Katayama, O Sekine, Y Usuda, N Aoki, T Cho, T Oyanagi, T Masuda, N Maekawa, M Nakanishi, M Kawai, T Kurasawa, H Nishiyama, K Bando, N Sakurai, S Muto, T Murayama, T Tsujimoto, S Hayashi
JournalKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases (Kansenshogaku Zasshi) Vol. 56 Issue 11 Pg. 1045-91 (Nov 1982) ISSN: 0387-5911 [Print] Japan
PMID6819327 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Leucomycins
  • Miocamycin
  • midecamycin
Topics
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Leucomycins (therapeutic use)
  • Male
  • Middle Aged
  • Miocamycin
  • Pneumonia (drug therapy)
  • Pneumonia, Mycoplasma (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: